Independent evidence. Executive judgement. Clear strategic choices.
Leadership teams often have abundant internal information but limited time to reconcile it with market reality. Our executive advisory provides an independent evidence-led perspective that challenges assumptions, clarifies choices and frames implications.

What we analyse
- Strategic market reviews
- Growth and portfolio discussions
- Board / leadership briefing support
- Market-entry and investment decisions
- Competitive response scenarios
- Technology and disruption reviews
- Opportunity prioritisation workshops
- Independent challenge to internal assumptions
Questions this work helps answer
- What does the external evidence say?
- Where do internal assumptions need testing?
- What are the strategic options, critical uncertainties and decision criteria?
How we create decision value
Advisory may be a focused executive briefing, a workshop supported by custom intelligence, or an ongoing cadence of market and competitor reviews. The format follows the decision cycle rather than forcing every requirement into a long report.

Typical outputs
- Concise evidence base
- Critical uncertainties
- Strategic options
- Implications
- Decision criteria
- Recommended next actions
Delivered across our industries
Every engagement is staffed by analysts who have worked inside the sector they are covering.
Pharmaceuticals
Therapeutic areas, access, pricing and tender dynamics
View coverage →Medical Devices
Diagnostics, implants, imaging and connected care
View coverage →Petrochemicals
Feedstock economics, downstream margins and derivatives
View coverage →Oil & Gas
Upstream, midstream and the energy transition
View coverage →Bring an external intelligence lens to your next decision →
Tell us what you need to understand, decide or validate. We will use it to determine the right research approach and the level of depth required.
